1. Increased circular RNA hsa_circ_0012673 acts as a sponge of miR-22 to promote lung adenocarcinoma proliferation
    Xiyong Wang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  2. SIRT1 and microRNAs: the role in breast, lung and prostate cancers
    Hedyieh Karbasforooshan et al, 2018, Experimental Cell Research CrossRef
  3. A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer.
    Yiran Liang et al, 2018, Cell Death Dis CrossRef
  4. MicroRNAs and their role in environmental chemical carcinogenesis
    Minghui Li et al, 2018, Environ Geochem Health CrossRef
  5. Potential Roles of microRNAs in the Regulation of Monoamine Oxidase A in the Brain
    Yuki Higuchi et al, 2018, Front. Mol. Neurosci. CrossRef
  6. Breaking down the Contradictory Roles of Histone Deacetylase SIRT1 in Human Breast Cancer
    Khaldoun Rifaï et al, 2018, Cancers CrossRef
  7. miR-22 Regulates Invasion, Gene Expression and Predicts Overall Survival in Patients with Clear Cell Renal Cell Carcinoma
    Xue Gong et al, 2019, KCA CrossRef
  8. The Impact of microRNAs in Breast Cancer Angiogenesis and Progression
    Kontomanolis N. Emmanuel et al, 2019, MIRNA CrossRef
  9. Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells
    Sahar Yarahmadi et al, 2019, Gene CrossRef
  10. MicroRNA Regulation of Epigenetic Modifiers in Breast Cancer
    Brock Humphries et al, 2019, Cancers CrossRef
  11. null
    Nataly Naser Al Deen et al, 2019 CrossRef
  12. Genome-Wide Methylation Profiling in Canine Mammary Tumor Reveals miRNA Candidates Associated with Human Breast Cancer
    Su-Jin Jeong et al, 2019, Cancers CrossRef
  13. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer
    Jia Tang et al, 2019, Disease Markers CrossRef
  14. The role of noncoding RNAs and sirtuins in cancer drug resistance
    Fatemeh Zahedipour et al, 2020, European Journal of Pharmacology CrossRef
  15. Therapeutic Targeting of Cancer Metabolism with Triosephosphate Isomerase
    Gonca Pekel et al, 2020, C&B CrossRef
  16. MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway
    Yan Shu et al, 2017, Oncotarget CrossRef
  17. miR‑448 promotes progression of non‑small‑cell lung cancer via targeting SIRT1
    Hongfeng Qi et al, 2019, Exp Ther Med CrossRef
  18. Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
    Jun Sheng Wong et al, 2020, ncRNA CrossRef
  19. Bioinformatic gene analysis for potential therapeutic targets of Huntington’s disease in pre-symptomatic and symptomatic stage
    Chunchen Xiang et al, 2020, J Transl Med CrossRef
  20. Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles
    Nitish Kumar Mishra et al, 2020, Front. Genet. CrossRef
  21. Upregulation of mir-132 induces dopaminergic neuronal death via activating SIRT1/P53 pathway
    Talal Jamil Qazi et al, 2020, Neuroscience Letters CrossRef
  22. MiR-105-3p acts as an oncogene to promote the proliferation and metastasis of breast cancer cells by targeting GOLIM4
    Bo Lin et al, 2021, BMC Cancer CrossRef
  23. Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy
    Runze Wang et al, 2021, Front. Cell Dev. Biol. CrossRef
  24. Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer
    Tatiana Kalinina et al, 2021, Genes CrossRef
  25. MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers
    Kazem Nejati et al, 2021, Pathology - Research and Practice CrossRef
  26. MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53.
    Zohreh Abdolvahabi et al, 2019, J Cell Biochem CrossRef
  27. A review study on the modulation of SIRT1 expression by miRNAs in aging and age-associated diseases
    Aliabbas Zia et al, 2021, International Journal of Biological Macromolecules CrossRef
  28. null
    Ashok Kumar et al, 2021 CrossRef
  29. lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus
    Hai-Ting Liu et al, 2021, Cell Death Differ CrossRef
  30. Unveiling Role of MicroRNAs as Treatment Strategy and Prognostic Markers in Triple Negative Breast Cancer
    Acharya Balkrishna et al, 2020, CPB CrossRef
  31. Downregulation of MicroRNA-147 Inhibits Cell Proliferation and Increases the Chemosensitivity of Gastric Cancer Cells to 5-Fluorouracil by Directly Targeting PTEN
    Jianjun Shen et al, 2018, oncol res CrossRef
  32. Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA / mRNA expression analysis
    Snehal Nirgude et al, 2022, Cancer Reports CrossRef
  33. Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer
    Deniz Mortazavi et al, 2022, Journal of Oncology CrossRef
  34. A perspective on the diagnostics, prognostics, and therapeutics of microRNAs of triple-negative breast cancer
    Rama Rao Malla et al, 2019, Biophys Rev CrossRef
  35. Characteristics, Whole-Genome Sequencing and Pathogenicity Analysis of Escherichia coli from a White Feather Broiler Farm
    Shaopeng Wu et al, 2023, Microorganisms CrossRef